| CAS | Product Name | MF |
|
120484-65-3
|
H-LEU-PRO-PRO-SER-ARG-OH
|
C25H44N8O7
|
|
193527-91-2
|
1-(4-IODOPHENYL)-3-(2-ADAMANTYL)GUANIDINE
|
C17H22IN3
|
|
634207-53-7
|
8-pCPT-2μ-O-Me-cAMP
|
C17H16ClN5NaO6PS
|
|
34232-27-4
|
5,8-Dihydroxy-2-[(S)-1-acetoxy-4-methyl-3-pentenyl]-1,4-naphthalenedione
|
C18H18O6
|
|
477845-12-8
|
4-[3-(4-Chlorophenyl)-2,1-benzisoxazol-5-yl]-2-pyrimidinamine
|
C17H11ClN4O
|
|
957136-80-0
|
cis-4-(2,2,3-Trimethylcyclopentyl)butanoic acid
|
C12H22O2
|
|
208038-27-1
|
1-[(3α,5β,7α)-3,7-Dihydroxycholan-24-oate] β-D-Glucopyranuronic Acid
|
C30H48O10
|
|
161314-17-6
|
AcetaMide, N-hydroxy-2-[[(4-Methoxyphenyl)sulfonyl](2-Methylpropyl)aMino]-
|
C13H20N2O5S
|
|
133898-77-8
|
Kansuiphorin C
|
C29H34O6
|
|
108321-79-5
|
N-ACETYLGLUCOSAMINE 6-SULFATE SODIUM SALT
|
C8H14NNaO9S
|
|
676500-67-7
|
5-(2-Methoxy-4-(((2-(tetrahydro-2H-pyran-4-yl)ethyl)amino)methyl)phenoxy)pyrazine-2-carboxamide
|
C20H26N4O4
|
|
381168-77-0
|
N-(3,4-difluorophenyl)-2-pyridin-4-ylquinazolin-4-amine
|
C19H12F2N4
|
|
1206-49-1
|
1-(2,6-DIMETHYL-PHENYL)-PYRROLE-2,5-DIONE
|
C12H11NO2
|
|
1382799-40-7
|
MIK-8719
|
C9H14F2N2O3S
|
|
2411141-56-3
|
7-chloronaphtho[1,2-b]benzofuran
|
C16H9ClO
|
|
2369751-07-3
|
Ethanone, 1-?[6,?7-?dichloro-?1,?3,?4,?5-?tetrahydro-?9-?(1-?methyl-?1H-?pyrazol-?3-?yl)?-?2H-?pyrido[4,?3-?b]?indol-?2-?yl]?-?2-?hydroxy-
|
C17H16Cl2N4O2
|
|
112247-65-1
|
Biotin-[2-(2-pyridyldithio)ethylamide]
|
C17H24N4O2S3
|
|
1436861-97-0
|
Zidebactam
|
C13H21N5O7S
|
|
190085-41-7
|
Benzoic acid, 2-hydroxy-, 2-butyloctyl ester
|
C19H30O3
|
|
861249-59-4
|
6-(3-methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine
|
C18H15N5O
|
|
313526-24-8
|
Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]-
|
C24H20N2O2S
|
|
1422496-28-3
|
2,4-DICHLORO-1,6-NAPHTHYRIDINE
|
C8H4Cl2N2
|
|
4613-78-9
|
BETA-GENTIOBIOSE OCTAACETATE
|
C28H38O19
|
|
52869-18-8
|
N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide
|
C21H13NO3
|
|
1353219-05-2
|
Peficitinib hydrobromide
|
C18H22N4O2. HBr
|
|
568544-03-6
|
2-CHLORO-N-(4-CHLORO-3-DIMETHYLSULFAMOYL-PHENYL)-ACETAMIDE
|
C10H12Cl2N2O3S
|
|
2212021-55-9
|
1,2-Hydrazinedicarboxylic acid, 1-(4-fluoro-3,5-dimethylphenyl)-, 1,2-bis(1,1-dimethylethyl) ester
|
C18H27FN2O4
|
|
6705-51-7
|
1,2-Epoxy-3-cyclohexene
|
C6H8O
|
|
847180-48-7
|
Cy7.5
|
C43H46N2O14S4
|
|
20718-41-6
|
4-Nitro-2,1,3-benzoselenadiazole
|
C6H3N3O2Se
|
|
2173134-00-2
|
vanin-1 inhibitor
|
C18H22N6O2
|
|
10294-68-5
|
INDIUM SULFATE
|
H18In2O21S3
|
|
19574-66-4
|
3-(benzyhdryloxy) propane-1,2-diol
|
C16H18O3
|
|
351325-31-0
|
5-BroMo-2,4-difluoro-benzoic acid Methyl ester
|
C8H5BrF2O2
|
|
19813-90-2
|
4-Phenylbenzenethiol
|
C12H10S
|
|
227449-73-2
|
Syk Inhibitor II
|
C14H16ClF3N6O
|
|
1415340-63-4
|
MI-192
|
C24H21N3O2
|
|
55974-42-0
|
ARC 239 dihydrochloride
|
C24H30ClN3O3
|
|
1638644-62-8
|
6-Chloro-10,11,14,17-tetrahydro-13H-1,16-etheno-4,8-metheno-1H-pyrazolo[3,4-g][1,14,4,6]dioxadiazacyclohexadecine hydrochloride
|
C16H15ClN4O2
|
|
2173556-69-7
|
Carbamic acid, N-[5-[2-(acetylamino)-6-benzothiazolyl]-2-methyl-3-pyridinyl]-, cyclohexyl ester
|
C22H24N4O3S
|
|
887407-16-1
|
N-NITROSOANATABINE
|
C10H11N3O
|
|
632-32-6
|
CAMPESTEROL 1X1ML CHLOROFORM 100UG/ML
|
C28H48O
|
|
2494-12-4
|
N-acetyldopamine
|
C10H13NO3
|
|
22691-02-7
|
CALCIUM CHLORIDE HYDRATE
|
CaCl2H2O
|
|
76808-16-7
|
EBELACTONE A
|
C20H34O4
|
|
330459-31-9
|
tioxazafen
|
C12H8N2OS
|
|
1369767-20-3
|
1369767-20-3
|
C11H13FO2
|
|
930800-38-7
|
N-Hex-5-ynyl-2-iodo-acetamide
|
C8H12INO
|
|
874484-20-5
|
S29434
|
C21H18N4O3
|
|
1922098-69-8
|
3-Piperidinecarboxamide, N-(4-chlorophenyl)-5,5-difluoro-1-[3-(2-furanyl)benzoyl]-
|
C23H19ClF2N2O3
|
|
1169768-28-8
|
6,9,28,31-Heptatriacontatetraen-19-ol, (6Z,9Z,28Z,31Z)-
|
C37H68O
|
|
2407782-01-6
|
LDC7559
|
C20H19N3O3
|
|
5467-79-8
|
6-METHOXY-2-QUINOLINECARBONITR
|
C11H8N2O
|
|
1150-59-0
|
4-hydroxy-3-phenyl-naphthalene-1,2-dione
|
C16H10O3
|
|
1621-24-5
|
1-CYCLOPROPYL-ETHYLAMINE
|
C5H11N
|
|
1234844-11-1
|
GPR120 Agonist 2
|
C22H25ClO4
|
|
1355170-97-6
|
5-(Tert-Butoxycarbonyl)-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A][1,4]Diazepine-2-Carboxylic Acid(WX141418)
|
C13H19N3O4
|
|
117221-65-5
|
Neolancerin
|
C19H18O10
|
|
71324-20-4
|
4-HYDROXY-3-METHOXY-D3-PHENYLETHYLENE GLYCOL 4-SULPHATE POTASSIUM SALT
|
C9H11O7S.K
|
|
732973-87-4
|
GOT1 inhibitor 2c
|
C19H19ClN4O
|
|
510733-97-8
|
ATC 0175
|
C23H25F2N5O.ClH
|
|
2607829-38-7
|
2-Butenamide, N-[4-[(3-chloro-2-fluorophenyl)amino]-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hex-1-yl]ethynyl]-6-quinazolinyl]-4-(4-morpholinyl)-, (2E)-
|
C30H30ClFN6O2
|
|
1197-51-9
|
BENZYL-PROP-2-YNYL-AMINE
|
C10H11N
|
|
75853-60-0
|
DEHYDROEVODIAMINE HYDROCHLORIDE
|
C19H16N3O.Cl
|
|
89354-45-0
|
Riligustilide
|
C24H28O4
|
|
331770-21-9
|
Aurora Kinase Inhibitor II
|
C23H20N4O3
|
|
4985-70-0
|
1-CHLOROANTHRACENE
|
C14H9Cl
|
|
1151-14-0
|
2-(4-ETHYLBENZOYL)BENZOIC ACID
|
C16H14O3
|
|
121887-11-4
|
Phen-2,3,4,5-d4-ol, 6-amino-
|
C6H3D4NO
|
|
1786438-30-9
|
(R)-CR8 (trihydrochloride)
|
C24H30ClN7O
|
|
2448173-47-3
|
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
|
C33H40N8O4
|
|
120005-55-2
|
CAY10621
|
C26H45NO4
|
|
62948-75-8
|
URIC ACID (1,3-15N2)
|
C5H4N4O3
|
|
1821370-28-8
|
MitoPQ
|
C39H46IN2P+2
|
|
1962928-26-2
|
BGC 20-1531 (hydrochloride)
|
C26H25ClN2O6S
|
|
53430-50-5
|
Syringetin-3-O-rutinoside
|
C29H34O17
|
|
2109805-56-1
|
CLK inhibitor T3
(T3)
|
C28H30N6O2
|
|
680622-70-2
|
O6-[4-(TRIFLUOROACETAMIDOMETHYL)BENZYL]GUANINE
|
C15H13F3N6O2
|
|
40034-42-2
|
rosoxacin
|
C17H14N2O3
|
|
2505001-62-5
|
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide
|
C16H19Cl2N3O4S
|
|
83329-89-9
|
2-[(8-chloro-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluoroctyl)oxyl]-1,1,2,2-tetrafluoro-ethanesulfonic acid,potassium salt
|
C10H2ClF20KO4S
|
|
142451-65-8
|
kaempferol-3-O-glucosyl(1-2)rhamnoside
|
C27H30O15
|
|
2739866-40-9
|
ALK-IN-27
|
C23H22ClFN6O
|
|
1014689-18-9
|
SUDAN IV-D6
|
C24H20N4O
|
|
851636-83-4
|
CYSMETHYNIL
|
C25H32N2O
|
|
23943-93-3
|
LAPPACONINE
|
C23H37NO6
|
|
1467047-25-1
|
AA9
|
C22H28N2O2
|
|
460330-27-2
|
GT 949
|
C30H37N7O2
|
|
1962160-86-6
|
(2S)-2-[(2S,3R)-3-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]-3-phenylpropanoic acid
|
C32H36N2O6
|
|
81-37-8
|
FLUOROL YELLOW 088
|
C22H16O
|
|
2418670-70-7
|
1,4-Benzenedisulfonamide, N4-[3-chloro-2-(1-piperidinyl)phenyl]-N1,N1-dimethyl-
|
C19H24ClN3O4S2
|
|
2758907-91-2
|
2-Thiophenecarboxylic acid, 5-acetyl-3-methyl-
|
C8H8O3S
|
|
22840-91-1
|
didimethylsulfoxide dichloroplatinum(II)
|
2C2H6OS.Cl2Pt
|
|
1334529-08-6
|
6,7-Dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Perchlorate
|
C14H18ClN3O4
|
|
1367351-41-4
|
Minimolide F
|
C19H26O5
|
|
593-40-8
|
PETROSELAIDIC ACID
|
C18H34O2
|
|
819850-16-3
|
2-PYRIMIDIN-2-YL-PROPIONIC ACID
|
C7H8N2O2
|
|
1802632-22-9
|
CT-1812
|
C24H33NO4S
|
|
1263358-13-9
|
Trazodone impurity 3/Trazodone Bromo Analog/2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
|
C19H22BrN5O
|
|
1256349-48-0
|
1-Naphthalenecarboxamide, N-(2-aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-
|
C27H21N3O3
|